Over the last few decades, the presentation of primary hyperparathyroidism (pHPT) has changed with a decline in the classic symptoms to a milder ''asymptomatic'' form of the disease. This has lead some experts to suggest clinical observation of these milder forms of pHPT may be justified. However, increasing evidence suggests many of these supposedly ''asymptomatic'' patients are actually plagued with vague, non-specific symptoms. The utilization of neuropsychiatric assessment tools, QOL instruments, and disease-specific patient-based measures of health have demonstrated the positive impact of parathyroidectomy on these symptoms. End-organ effects of pHPT on the heart and cardiovascular system may result in a relatively higher mortality risk and there is evidence to suggest the possibility of normalizing this risk with early surgical intervention. This increased body of data suggests that surgical intervention should be considered in all patients diagnosed with HPT.